Categories AlphaGraphs, Earnings, Health Care
Eli Lilly (LLY) reports Q1 2020 earnings results
Adjusts EPS guidance amid COVID19 pandemic
Pharmaceutical company Eli Lilly (NYSE: LLY) reported first quarter 2020 revenue of $5.86 billion, up 15% year-over-year.
Amid COVID-19 pandemic, the company saw increased customer buying patterns and prescription trends which resulted in revenue increase of approx. $250 million for the quarter.
Net income was $1.457 billion or $1.60 per share, compared with net income of $4.242 billion or $4.31 per in the first quarter of 2019.
Josh Smiley, CFO commented on the outlook:
“Our revenue and operating margin outlook for 2020 is unchanged, but the economic and healthcare consequences of this pandemic are uncertain and could negatively affect our financial results later in 2020 and beyond, due to reduced non-COVID healthcare activities and global economic challenges. We are therefore widening the range of our 2020 EPS guidance to reflect both our underlying strong performance as well as future uncertainty; however, the long-term fundamentals of our business remain strong, as does our financial outlook for the mid-2020s and beyond.”
Past Performance
Most Popular
Hormel (HRL) expects earnings pressure to continue into Q1 2026
Shares of Hormel Foods Corporation (NYSE: HRL) gained over 3% on Thursday. The company delivered mixed results for the fourth quarter of 2025, as earnings came ahead of expectations while
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
